Cell therapy in end-stage liver disease: replace and remodel
XH Hu, L Chen, H Wu, YB Tang, QM Zheng… - Stem Cell Research & …, 2023 - Springer
Liver disease is prevalent worldwide. When it reaches the end stage, mortality rises to 50%
or more. Although liver transplantation has emerged as the most efficient treatment for end …
or more. Although liver transplantation has emerged as the most efficient treatment for end …
Restoration of blood vessel regeneration in the era of combination SGLT2i and GLP-1RA therapy for diabetes and obesity
Ischaemic cardiovascular diseases, including peripheral and coronary artery disease,
myocardial infarction, and stroke, remain major comorbidities for individuals with type 2 …
myocardial infarction, and stroke, remain major comorbidities for individuals with type 2 …
Decellularized adipose tissue scaffolds guide hematopoietic differentiation and stimulate vascular regeneration in a hindlimb ischemia model
Cellular therapies to stimulate therapeutic angiogenesis in individuals with critical limb
ischemia (CLI) remain under intense investigation. In this context, the efficacy of cell therapy …
ischemia (CLI) remain under intense investigation. In this context, the efficacy of cell therapy …
Lactate enhances mouse ES cell differentiation toward XEN cells in vitro
Metabolism plays a crucial role for cell survival and function; however, recent evidence has
implicated it in regulating embryonic development. In the embryo, the inner cell mass …
implicated it in regulating embryonic development. In the embryo, the inner cell mass …
[HTML][HTML] Aldehyde Dehydrogenase Enzyme Functions in Acute Leukemia Stem Cells
GM Dancik, IF Voutsas, S Vlahopoulos - Frontiers in Bioscience …, 2022 - imrpress.com
The enzymes that belong to the aldehyde dehydrogenase family are expressed in a variety
of cells; yet activity of their main members characterizes stem cells, both normal and …
of cells; yet activity of their main members characterizes stem cells, both normal and …
Characterization of a Vimentinhigh/Nestinhigh proteome and tissue regenerative secretome generated by human pancreas-derived mesenchymal stromal cells
Multipotent/mesenchymal stromal cells (MSCs) exist within a variety of postnatal tissues;
however, global proteomic analyses comparing tissue-specific MSC are limited. Using …
however, global proteomic analyses comparing tissue-specific MSC are limited. Using …
Alda-1, an aldehyde dehydrogenase 2 agonist, improves cutaneous wound healing by activating epidermal keratinocytes via Akt/GSK-3β/β-catenin pathway
S Zhang, C Chen, J Ying, C Wei, L Wang, Z Yang… - Aesthetic Plastic …, 2020 - Springer
Background The cutaneous wound healing process mainly comprises re-epithelialization,
fibrosis, and neovascularization. Impaired wound healing is common but tricky in plastic …
fibrosis, and neovascularization. Impaired wound healing is common but tricky in plastic …
Ultrafiltration and injection of islet regenerative stimuli secreted by pancreatic mesenchymal stromal cells
TT Cooper, SE Sherman, GI Bell… - Stem Cells and …, 2021 - liebertpub.com
The secretome of mesenchymal stromal cells (MSCs) is enriched for biotherapeutic effectors
contained within and independent of extracellular vesicles (EVs) that may support tissue …
contained within and independent of extracellular vesicles (EVs) that may support tissue …
Advances in ex vivo expansion of hematopoietic stem and progenitor cells for clinical applications
A Branco, J Rayabaram, CC Miranda… - … in Bioengineering and …, 2024 - frontiersin.org
As caretakers of the hematopoietic system, hematopoietic stem cells assure a lifelong supply
of differentiated populations that are responsible for critical bodily functions, including …
of differentiated populations that are responsible for critical bodily functions, including …
GLP-1RA therapy increases circulating vascular regenerative cell contentin people living with type 2 diabetes
B Park, A Krishnaraj, H Teoh… - American Journal …, 2024 - journals.physiology.org
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2
(SGLT2) inhibitors are guideline-recommended therapies for the management of type 2 …
(SGLT2) inhibitors are guideline-recommended therapies for the management of type 2 …